Israel Englander Bio Techne Corp Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $709,599 - $823,500	-10,000 Reduced 33.33%	20,000 $1.6 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $242,268 - $328,185	3,900 Added 14.94%	30,000 $2.15 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $72,578 - $84,799	1,100 Added 4.4%	26,100 $1.84 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $528,300 - $782,200	10,000 Added 66.67%	25,000 $1.93 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $368,800 - $429,900	5,000 Added 50.0%	15,000 $1.22 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $716,200 - $866,200	10,000 New	10,000 $742,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $4.8 Million - $6.66 Million	17,000 New	17,000 $4.83 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.